Catherine Johnson MD (@catjohnsonmd) 's Twitter Profile
Catherine Johnson MD

@catjohnsonmd

Board Certified Emergency Physician & Board Certified Obesity Medicine Physician, Founder & Medical Director of Precision Medical Care, LLC

ID: 630350156

linkhttp://www.myprecisionmedicalcare.com calendar_today08-07-2012 16:48:43

474 Tweet

1,1K Followers

1,1K Following

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟 fda.gov/news-events/pr…

🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟

fda.gov/news-events/pr…
Catherine Johnson MD (@catjohnsonmd) 's Twitter Profile Photo

Only 6% of eligible patients pursued either GLP-1 treatment or surgery, highlighting a vast unmet need in obesity care. Let’s do better in 2025! It is a challenge to treat excess weight yet SO many people are WORTHY of achieving their health goals this year! #Resolutions2025

Catherine Johnson MD (@catjohnsonmd) 's Twitter Profile Photo

Yes!! Precision Medicine = precision monitoring, intervention and resilience for sustainable healthy longevity 🎯 2025 will be an exceptional year for improving the awareness, access and IMPACT of #precisionmedicine 🏆

Eric Topol (@erictopol) 's Twitter Profile Photo

How the brain gets rid of its chemical waste through the glymphatics during sleep, via blood vessel oscillations, regulated by norepinephrine. Impeded by Ambien. cell.com/cell/abstract/… Cell science.org/content/articl… Science Magazine

How the brain gets rid of its chemical waste through the glymphatics during sleep, via blood vessel oscillations, regulated by norepinephrine. Impeded by Ambien.
cell.com/cell/abstract/… <a href="/CellCellPress/">Cell</a> 
science.org/content/articl… <a href="/ScienceMagazine/">Science Magazine</a>
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

The FDA has approved #semaglutide for treating chronic kidney disease #CKD in adults with type 2 diabetes to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death, based on the results of the FLOW trial which demonstrated a 24% reduction in major

The FDA has approved #semaglutide for treating chronic kidney disease #CKD in adults with type 2 diabetes to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death, based on the results of the FLOW trial which demonstrated a 24% reduction in major
Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

The Physiology of Hunger: NEJM 🥸 So this is not in CV medicine, but: (1) it is interesting and (2) it has implications for CV 😱 Good job NEJM - Summary 👇👇👇

The Physiology of Hunger: <a href="/NEJM/">NEJM</a> 

🥸 So this is not in CV medicine, but: 
(1) it is interesting and (2) it has implications for CV 

😱 Good job <a href="/NEJM/">NEJM</a> - Summary 

👇👇👇
Dutch Rojas (@dutchrojas) 's Twitter Profile Photo

If the American People Only Knew… Same Surgery, Same Surgeon, Medicare Pays 2x More To Health Systems for No Reason The government claims to care about efficiency. Yet Medicare pays significantly more when a procedure is performed in a health system, owned outpatient

Nicholas Fabiano, MD (@ntfabiano) 's Twitter Profile Photo

After just one night of sleep deprivation, the brain begins to accumulate β-amyloid - a key protein in Alzhiemer’s dementia. 🧵1/10

After just one night of sleep deprivation, the brain begins to accumulate β-amyloid - a key protein in Alzhiemer’s dementia.

🧵1/10
Raffaele Di Giacomo, PhD (@sciqst) 's Twitter Profile Photo

Johns Hopkins Ciccarone Center Captivating insights! This study underscores the importance of not solely relying on Coronary Artery Calcium (CAC) as the marker for low cardiovascular risk. Incorporating Thoracic Aortic Calcium (TAC) measurements could be vital for better risk stratification. This opens up new

Dutch Rojas (@dutchrojas) 's Twitter Profile Photo

Insurance companies don’t pay for healthcare. Employers do. Patients do. Physicians do. Carriers just take a cut, while inflating costs and denying claims. The solution? Cut them out. Physician-led health plans are the future. #healthcare

Catherine Johnson MD (@catjohnsonmd) 's Twitter Profile Photo

Your ancestry may not impact your candidacy for a job but it definitely matters to your candidacy for preventive medicine #precisionmedicine

Catherine Johnson MD (@catjohnsonmd) 's Twitter Profile Photo

“In midlife, women experience an average ANNUAL weight increase of 0.7 kg (1.5 lb) and by 2030 it is projected that ~75% of US women will be living with obesity or overweight.”

Dr Alo, DO, FACC (@mohammedalo) 's Twitter Profile Photo

Lepodisiran Reduced Lp(a) Levels By Upto 95% 1️⃣ Elevated lp(a) levels are strongly associated with increased risk of atherosclerotic cardiovascular disease. 2️⃣ This new study tested lepodisiran—an extended-duration small interfering RNA (siRNA) that targets hepatic production

Lepodisiran Reduced Lp(a) Levels By Upto 95%

1️⃣ Elevated lp(a) levels are strongly associated with increased risk of atherosclerotic cardiovascular disease.

2️⃣ This new study tested lepodisiran—an extended-duration small interfering RNA (siRNA) that targets hepatic production
Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨BREAKING: Lilly’s oral GLP-1, orforglipron, hits its primary endpoint in the Phase 3 ACHIEVE-1 trial for type 2 diabetes. 🔸A1C↓ by 1.3–1.6% 🔸Weight loss: up to 16 lbs (7.9%) 🔸65%+ hit A1C ≤6.5% Once-daily, oral small molecule GLP-1—no food/water restrictions Safety

🚨BREAKING: Lilly’s oral GLP-1, orforglipron, hits its primary endpoint in the Phase 3 ACHIEVE-1 trial for type 2 diabetes.
🔸A1C↓ by 1.3–1.6%
🔸Weight loss: up to 16 lbs (7.9%)
🔸65%+ hit A1C ≤6.5%
Once-daily, oral small molecule GLP-1—no food/water restrictions

Safety